(Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | (FY)Aug 31, 2022 | (Q4)Aug 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -73.23%105.38K | -90.21%47.56K | -81.71%156.48K | -95.60%56.81K | -95.60%56.81K | -77.74%393.61K | -77.18%485.9K | -66.11%855.49K | -63.15%1.29M | -63.15%1.29M |
-Cash and cash equivalents | -73.23%105.38K | -90.21%47.56K | -81.71%156.48K | -95.60%56.81K | -95.60%56.81K | -77.74%393.61K | -77.18%485.9K | -66.11%855.49K | -63.15%1.29M | -63.15%1.29M |
-Accounts receivable | -52.78%6.83K | -58.64%4.96K | -57.53%2.23K | 1,046.95%85.82K | 1,046.95%85.82K | 61.31%14.47K | 64.15%12K | 115.35%5.25K | -71.59%7.48K | -71.59%7.48K |
Total current assets | -81.67%121.09K | -83.87%96.82K | -74.87%253.87K | -79.03%286.2K | -79.03%286.2K | -64.51%660.63K | -73.89%600.35K | -63.18%1.01M | -64.15%1.36M | -64.15%1.36M |
Non current assets | ||||||||||
-Long term equity investment | --0 | --15.98K | --15.98K | --15.92K | --15.92K | ---- | ---- | ---- | --0 | --0 |
-Other intangible assets | 2.78%3.89M | 2.03%3.79M | 2.30%3.79M | 3.54%3.79M | 3.54%3.79M | 7.94%3.78M | 5.83%3.71M | 6.11%3.7M | 4.83%3.66M | 4.83%3.66M |
Regulatory assets | -52.78%6.83K | -58.64%4.96K | -57.53%2.23K | 1,046.95%85.82K | 1,046.95%85.82K | 61.31%14.47K | 64.15%12K | 115.35%5.25K | -71.59%7.48K | -71.59%7.48K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | --591.39K | --524.19K | --452.71K | --307.56K | --307.56K | ---- | ---- | ---- | ---- | ---- |
-Current debt | --591.39K | --504.48K | --424.12K | --270.37K | --270.37K | ---- | ---- | ---- | ---- | ---- |
-Current capital lease obligation | --0 | --19.7K | --28.59K | --37.19K | --37.19K | ---- | ---- | ---- | --0 | --0 |
-accounts payable | -92.87%7.05K | -13.76%27.95K | 232.23%17.23K | -72.17%5.06K | -72.17%5.06K | 52.17%98.93K | 39.50%32.41K | -75.60%5.19K | -82.19%18.19K | -82.19%18.19K |
-Total tax payable | --0 | --15.98K | --15.98K | --15.92K | --15.92K | --0 | --0 | --0 | --0 | --0 |
-Due to related parties current | -16.67%2.5K | --14.62K | -18.43%8.87K | -86.55%3K | -86.55%3K | -86.89%3K | --0 | 20.80%10.87K | -59.74%22.31K | -59.74%22.31K |
-Other payable | -37.54%114.85K | -37.87%114.29K | -37.35%114.39K | -35.70%113.96K | -35.70%113.96K | 7.55%183.88K | 7.17%183.96K | 5.60%182.6K | -3.88%177.23K | -3.88%177.23K |
Current accrued expenses | --0 | --0 | -14.00%21.5K | 32.00%33K | 32.00%33K | --0 | --0 | 35.14%25K | 6.38%25K | 6.38%25K |
Current liabilities | 472.71%600.94K | 1,648.88%566.76K | 1,118.53%500.31K | 432.25%348.62K | 432.25%348.62K | 19.37%104.93K | 10.17%32.41K | -15.79%41.06K | -63.82%65.5K | -63.82%65.5K |
Non current liabilities | ||||||||||
-Long term debt | --0 | --15.98K | --15.98K | --15.92K | --15.92K | ---- | ---- | ---- | --0 | --0 |
Non current accrued expenses | -11.61%3.34M | -23.17%3.35M | -21.05%3.31M | -17.01%3.28M | -17.01%3.28M | -5.18%3.78M | 19.86%4.36M | 20.21%4.19M | 46.38%3.95M | 46.38%3.95M |
Total non current liabilities | 472.71%600.94K | 1,698.18%582.74K | 1,157.45%516.28K | 456.55%364.54K | 456.55%364.54K | 19.37%104.93K | 10.17%32.41K | -15.79%41.06K | -63.82%65.5K | -63.82%65.5K |
Shareholders'equity | ||||||||||
Share capital | -0.00%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 0.00%23.27M | 0.00%23.27M | 0.00%23.27M | 0.00%23.27M |
-common stock | -0.00%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 2.14%23.77M | 0.00%23.27M | 0.00%23.27M | 0.00%23.27M | 0.00%23.27M |
Total equity | -22.64%3.58M | -30.78%3.56M | -31.70%3.68M | -33.04%3.68M | -33.04%3.68M | -23.16%4.63M | -15.80%5.14M | -15.92%5.38M | -17.92%5.49M | -17.92%5.49M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.